# Intuitive Surgical, Inc.  Share Price Target ‘$410.80’, now 6.3% Upside Potential

- Link: https://www.directorstalkinterviews.com/intuitive-surgical-inc.share-price-target-410.80-now-6.3-upside-potential/4121145309
- Published: 2024-02-29T14:11:24+00:00
- Author: Charlotte Edwards

**Intuitive Surgical, Inc.** with ticker code (ISRG) now have 23 analysts in total
covering the stock. The consensus rating is pointing to ‘buy’. The target price 
High/Low ranges between $460.00 and $322.50 with the average share target price 
sitting at $410.80. (at the time of writing). Given that the stocks previous close
was at $386.46 this indicates there is a potential upside of 6.3%. It’s also worth
noting that there is a 50 day moving average of $363.20 and the 200 day MA is $320.25.
The market capitalization for the company is 136.21B. The stock price for the company
is currently $386.59 USD

 The potential market cap would be $144,784,213,290 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 76.86, revenue per share of $20.29
and a 7.77% return on assets.

Intuitive Surgical, Inc. develops, manufactures, and markets the da Vinci surgical
system and the Ion endoluminal system. The Company’s products and related services
enable physicians and healthcare providers to access minimally invasive care. The
systems consist of a surgeon console or consoles, a patient-side cart, a vision 
system, and instruments and accessories. Its da Vinci products consist of five categories,
such as da Vinci surgical systems, da Vinci instruments and accessories, da Vinci
Stapling, da Vinci Energy, and da Vinci Vision, including Firefly Fluorescence imaging
systems and da Vinci Endoscopes. It also provides a suite of systems, learning, 
and services offerings. Its Ion endoluminal system extends its commercial offerings
beyond surgery into diagnostic procedures, enabling minimally invasive biopsies 
in the lung. Its services include readiness support, maintenance support, perioperative
consulting, customer hospital analytics, and market consulting optimization.

Share on: